Body surface area involved | < 9% | 9–36% | > 36% |
Erythema | Mild | Moderate | Severe |
Course | Remission > 3 months in past year | Remission < 3 months in past year | Continuous |
| | | |
Score for topical glucocorticoid treatment (total 10)
|
1
|
2
|
3
|
4
|
Potency of preparation | Mild | Moderate | Potent | Very potent |
Body surface area treated | < 9% | 9–36% | > 36% | |
Treatment duration | ⩽ 7 days in past month | < 7 days in past month | Continuous | |
| | | | |
Score for coexisting asthma (total 8)
|
0
|
1
|
2
|
3
|
Number of exacerbations in a year | 0 | 1–3 | 4–6 | ⩾ 7 |
Interval symptoms | None | Intermittent | Continuous | – |
Treatment | None | Bronchodilators | Sodium cromoglycate | Inhaled glucocorticoid |